Hyaluronidase and trastuzumab and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Hyaluronidase and trastuzumab and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hyaluronidase / trastuzumab
Brand name: Herceptin Hylecta
Synonyms: Trastuzumab and Hyaluronidase
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hyaluronidase and trastuzumab-Moxifloxacin
- Hyaluronidase and trastuzumab-Moxifloxacin (Systemic)
- Hyaluronidase and trastuzumab-Moxifloxacin Hydrochloride
- Hyaluronidase and trastuzumab-Moxifloxacin Injection
- Hyaluronidase and trastuzumab-Moxifloxacin Intravenous
- Hyaluronidase and trastuzumab-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Hyaluronidase injection
- Moxetumomab pasudotox-tdfk Intravenous-Hyaluronidase Injection (Human)
- Moxetumomab pasudotox-tdfk Intravenous-Hyaluronidase Subcutaneous, Injection
- Moxetumomab pasudotox-tdfk Intravenous-Hyate:C
- Moxetumomab pasudotox-tdfk Intravenous-Hybrisil
- Moxetumomab pasudotox-tdfk Intravenous-Hycamtin